Pfizer Independent Medical Education
Request for Proposals
Addressing Knowledge Gaps in AplasticAnemia
Competitive Grant Program – Pfizer Internal Review ProcessOverview
This competitive grant program seeks to support educational
activities that address knowledge gaps related to aplastic anemia.

Geographic Scope/Location of Project
Global – excluding the United States

Project Types and Area of Interest
Projects that will be considered for Pfizer support will focus on
improving the care of patients by addressing knowledge gaps in thefollowing areas:• early identification and diagnosis of aplastic anemia (AA) patients• awareness of AA, in order to ensure appropriate transition ofpatients to specialty clinical centers of excellence for care
• current standards for the treatment of AA and its complications• clinical management of special patient subpopulations (i.e.
Pediatrics or Elderly) and challenging cases of AA patients

Key Milestones• Application submission deadline: 25 June 2024
• Anticipated decision notification date: August 2024
• Anticipated project start date: October 2024

Funding Range and Project Length• Individual projects requsting up to $50,000 will be considered• 1 year to 18 months project length is preferred; maximum project

length of 2 years

I. Eligibility
Geographic Scope/Location of Project:•Global (excluding the United States)

Applicant Eligibility Criteria•

•

••
•
•

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional
schools; healthcare institutions (both large and small); professional organizations/medical societies;
medical education companies; and other entities with a mission related to healthcare professional
education and/or healthcare improvement.
Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., anindependent group of physicians not affiliated with a hospital, academic institution, or professionalsociety).
If the project involves multiple departments within an institution and/or between different institutions /organizations / associations, all institutions must have a relevant role and the requesting organizationmust have a key role in the project.
The applicant must be the project/program lead or an authorized designee of such individual (e.g.,
project/program lead’s grant coordinator).
The project/program lead must be an employee or contractor of the requesting organization.
Requesting organization must be legally able to receive award funding directly from Pfizer Inc.. Westrongly recommend that applicants confirm this with their organization or institution prior to submitting
an application. Grants awarded to organizations that are subsequently found to be unable to accept
funding directly from Pfizer Inc. may be subject to rescission.

II. Requirements
Date RFP Issued:•7 May 2024

Clinical Area:•

Aplastic Anemia

General Area of Interest for this RFP:
•Projects that will be considered for Pfizer support will focus on improving the care of patients byaddressing knowledge gaps in the following areas:• early identification and diagnosis of aplastic anemia (AA) patients• awareness of AA, in order to ensure appropriate transition of patients to specialty clinical centersof excellence for care
• current standards for the treatment of AA and its complications• clinical management of special patient subpopulations (i.e. Pediatrics or Elderly) and challenging
cases of AA patients
It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeuticor diagnostic agents will not be considered.

2Target Audience:•Healthcare providers involved in the identification, diagnosis, and management of aplastic anemia
patients, including primary care physicians, hematologists, hematologist oncologists

Expected Approximate Monetary Range of Grant Applications:••Individual projects requesting up to $50,000 will be considered. The estimated total available budget
related to this RFP is $100,000
Award amounts include direct costs, institutional overhead costs (capped at 28% per Pfizer policy),
and indirect costs.

Key Dates:•••••

RFP release date: 7 May 2024
Grant Application due date: 25 June 2024
Anticipated Grant Award Notification Date: August 2024
Grants will be distributed following a fully executed agreement.
Anticipated Project Start and End Dates: on or after October 2024 (1 year to 18 months project
length is preferred; maximum project length of 2 years)

How to Submit:
Note: Please read this section carefully since applications submitted not following these instructions will
not be accepted and will be cancelled.
• Please go to www.cybergrants.com/pfizer/knowledge and sign in. First-time users should click “Createyour password”. [Note: there are individual portals for each grant application type. Please be sure touse the URL above.]• Click the “Start A New Knowledge Gap Application" button.
• In the application:• For the question “What type of request are you submitting?” select Response to a Request for
Proposal (RFP)• For the question “Are you replying to a Request for Proposal (RFP) as part of the Competitive
Grant Program?” select Yes• Select the following Competitive Grant Program Name: 2024 HOS Global Aplastic Anemia
Education IME• Select the following Primary Area of Interest: Hematology-Aplastic Anemia• Requirements for submission:
Complete all required sections of the online application and upload your project proposal (seeAppendix) in the General RFP Submission field.
• If you encounter any technical difficulties with the website, please click the “Technical Questions” linkat the bottom of the page.
IMPORTANT: Be advised applications submitted after the due date will not be reviewed.

Questions:•If you have questions regarding this RFP, please direct them in writing to the Grant Officer, AmandaStein (amanda.j.stein@pfizer.com), with the subject line “Aplastic Anemia Education.”

Grant Agreements:•If your grant is approved, your institution will be required to enter into a written grant agreement withPfizer. Please click here to view the core terms of the agreement.

3

•

•
•

Under Pfizer's competitive grant program, modifications to grant agreements will not be reviewed
unless a genuine conflict exists as between applicable law and the terms of the relevant grantagreement. Applicant is encouraged to share the core terms with counsel for approval prior tosubmitting an application.
Except where prohibited by applicable law and, in any case, subject to review by Pfizer Legal,
payment of grant funding may only be paid to the grantee organization.
This RFP is supported by Pfizer Inc. and, if approved, payment will be sent from the United States.

Review and Approval Process:•Grant requests received in response to a general RFP are reviewed by Pfizer to make final grant
decisions.

Mechanism by which Applicants will be Notified:••

All applicants will be notified via email by the dates noted above.
Applicants may be asked for additional clarification during the review period.

About Pfizer Global Medical Grants
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g.,research, quality improvement, or education) to improve patient outcomes in areas of unmet medical needthat are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) thatprovides detail regarding a general area of interest, sets timelines for review and approval, and uses aninternal Pfizer review process to make final grant decisions. Organizations are invited to submit an application
addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is
responsible for the design, implementation, and conduct of the independent initiative supported by
the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of theindependent education program.

4Appendix
General RFP Submission Requirements
Applications will be accepted via the online portal listed in the How to Submit section. Project Proposals
should be single-spaced using Calibri 12-point font and 1-inch margins. Note there is a 12-page limit
exclusive of references. When uploading your Project Proposal please ensure it addresses the following
sections:Goals and Objectives••Briefly state the overall goal of the project.
List the objectives you plan to meet with your project, in terms of learning and expected outcomes.

Needs Assessment for the Project•

Include a description of your organization’s needs assessment for this proposed project which may
include a quantitative baseline data summary, initial metrics, or a project starting point (please cite dataon gap analyses or relevant patient-level data that informs the stated objectives) in your target area.

Target Audience•

Describe the primary audience(s) targeted for this project. Indicate whom you believe will directly benefit
from the project outcomes. Describe the overall population size as well as the size of your sample
population.

Project Design and Methods•

Describe the planned project, the educational approach, and the way the planned methods address theestablished need.

Innovation•Explain what measures you have taken to assure that this project is original and does not duplicate otherprojects or materials already developed. Describe how this project builds upon existing work, pilot
projects, or ongoing projects developed either by your institution or other institutions.

Evaluation and Outcomes•

In terms of the metrics used for the needs assessment, describe how your organization will determine if
the gap was addressed for the target group. Identify the sources of data your organization anticipatesusing to make the determination. Describe how your organization is expected to collect and analyze thedata. Explain the method used to control for other factors outside this project (e.g., use of a control groupor comparison with baseline data). Quantify the amount of change expected from this project in terms thetarget audience. Describe how your organization will determine if the target audience was fully engaged
in the project.

Dissemination Plan•

Describe how the project may have extended benefit beyond the grant. Will the teaching materials bemade available to others to use? Will there be tools or resources that are made publicly available
beyond the initial project. Describe how the project outcomes might be broadly disseminated.

Anticipated Project Timeline•

Provide an anticipated timeline for your project including project start/end dates.

5Additional Information•If there is any additional information you feel Pfizer should be aware of concerning the importance of thisproject, please summarize here.

Organization Detail•

Describe the attributes of the institutions / organizations / associations that will support and facilitate theexecution of the project and the leadership of the proposed project. Articulate the specific role of eachpartner in the proposed project.

Budget Detail••Please include a budget narrative that describes in greater detail the line items specified in the budget
submitted within the application.
While estimating your budget please keep the following items in mind:• Independent Medical Education Grants awarded by GMG cannot be used to purchase therapeuticassets (prescription or non-prescription).
• Overhead rates of up to 28% of the total proposed project budget may be supported by Pfizer.
Please click here for details. General organizational running costs such as legal fees, insurance,
heating, and lighting etc. should be included in an Institutional Overhead (if required). These costs
are not specific to a grant request and therefore, should not appear as line items in budgets.
However, costs that are specific to the study (e.g., some countries require insurance to be taken out
on a per-study basis for clinical research) would be acceptable to be included as line items.

6